Current
33.2×
5-Year Average
29.2×
All-Time High
381.2×
All-Time Low
3.3×
P/FCF Ratio daily chart for Humana (HUM)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
P/FCF ratio is not shown for periods when TTM free cash flow was negative.
Historical P/FCF Ratio for Humana (HUM) from 2001 to 2025
| 2025 | $30.82B | $375.00M | 82.2× | +69.4× | |
| 2024 | $30.55B | $2.39B | 12.8× | -6.1× | |
| 2023 | $56.06B | $2.98B | 18.8× | +0.3× | |
| 2022 | $64.35B | $3.47B | 18.6× | -44.5× | |
| 2021 | $59.66B | $946.00M | 63.1× | +51.5× | |
| 2020 | $54.19B | $4.67B | 11.6× | +0.9× | |
| 2019 | $48.55B | $4.55B | 10.7× | -14.4× | |
| 2018 | $39.12B | $1.56B | 25.1× | +15.1× | |
| 2017 | $35.06B | $3.52B | 9.9× | -11.7× | |
| 2016 | $30.51B | $1.41B | 21.7× | -55.4× | |
| 2015 | $26.59B | $345.00M | 77.1× | +57.1× | |
| 2014 | $21.79B | $1.09B | 20.0× | +7.4× | |
| 2013 | $16.10B | $1.28B | 12.6× | +5.4× | |
| 2012 | $10.90B | $1.51B | 7.2× | -1.1× | |
| 2011 | $14.30B | $1.73B | 8.3× | +3.7× | |
| 2010 | $9.14B | $2.02B | 4.5× | -1.4× | |
| 2009 | $7.36B | $1.24B | 6.0× | -2.7× | |
| 2008 | $6.21B | $720.74M | 8.6× | -4.2× | |
| 2007 | $12.64B | $985.02M | 12.8× | +6.7× | |
| 2006 | $9.14B | $1.49B | 6.1× | -12.8× | |
| 2005 | $8.69B | $459.78M | 18.9× | -1.2× | |
| 2004 | $4.70B | $233.71M | 20.1× | +8.3× | |
| 2003 | $3.68B | $311.87M | 11.8× | +3.2× | |
| 2002 | $1.79B | $209.27M | 8.6× | -49.8× | |
| 2001 | $1.98B | $33.99M | 58.3× | — |
- 202582.2×
- 202412.8×
- 202318.8×
- 202218.6×
- 202163.1×
- 202011.6×
- 201910.7×
- 201825.1×
- 20179.9×
- 201621.7×
- 201577.1×
- 201420.0×
- 201312.6×
- 20127.2×
- 20118.3×
- 20104.5×
- 20096.0×
- 20088.6×
- 200712.8×
- 20066.1×
- 200518.9×
- 200420.1×
- 200311.8×
- 20028.6×
- 200158.3×
About P/FCF Ratio at Humana (HUM)
Humana (HUM) P/FCF ratio is 33.2× as of June 5, 2026. The 5-year average is 29.2×. The sector median currently stands at 19.8×. The current ratio is at the 77th percentile of its own 10-year history.
Humana (HUM) historical P/FCF ratio has ranged from a low of 3.3× (2012) to a high of 381.2× (2015) in the available daily series.
The price-to-free-cash-flow (P/FCF) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) free cash flow. It is calculated as market cap ÷ TTM free cash flow, where free cash flow = operating cash flow − capital expenditures. Because FCF cannot be inflated by non-cash accounting items, P/FCF is often considered a cleaner measure of "earnings-power valuation" than P/E — especially for capital-intensive businesses where depreciation diverges from real cash outflows.
Humana P/FCF Ratio by Year
Humana P/FCF Ratio 2025: 82.2×
Humana (HUM) P/FCF ratio in 2025 was 82.2×, expanded from 12.8× the prior year.
Humana P/FCF Ratio 2024: 12.8×
Humana (HUM) P/FCF ratio in 2024 was 12.8×, contracted from 18.8× the prior year.
Humana P/FCF Ratio 2023: 18.8×
Humana (HUM) P/FCF ratio in 2023 was 18.8×, expanded from 18.6× the prior year.
Humana P/FCF Ratio 2022: 18.6×
Humana (HUM) P/FCF ratio in 2022 was 18.6×, contracted from 63.1× the prior year.
Humana P/FCF Ratio 2021: 63.1×
Humana (HUM) P/FCF ratio in 2021 was 63.1×.
Sector peers by P/FCF Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/FCF Ratio — table
Healthcare peers of Humana (HUM), ranked by P/FCF ratio.
| 18.5× | |
| 17.8× | |
| 17.8× | |
| 16.9× | |
| 16.9× | |
| 16.7× | |
| 16.3× | |
| 15.9× | |
| 14.0× | |
| 13.5× | |
| 12.9× | |
| 12.5× | |
| 12.4× | |
| 12.2× | |
| 12.1× | |
| 11.3× | |
| 10.7× | |
| 10.4× | |
| 10.3× | |
| 10.0× | |
| 9.6× | |
| 9.1× | |
| 9.1× | |
| 6.9× | |
| 2.5× |
- 18.5×
- 17.8×
- 16.9×
- 16.7×
- 13.5×
- 12.9×
- 12.4×
- 10.7×
- 10.3×
- 9.1×
- 9.1×
- 6.9×
- 2.5×
Frequently asked questions
Humana (HUM) Key Financials
Charts, filings, and peer comparison for every metric